Ginkgo diterpene lactone meglumine for functional recovery in patients with acute ischemic stroke: A systematic review and meta-analysis
- 28 January 2025
- journal article
- review article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 342, 119416
Abstract
No abstract availableKeywords
Funding Information
- China Academy of Chinese Medical Sciences
- State Administration of Traditional Chinese Medicine of The Peoples Republic of China
This publication has 21 references indexed in Scilit:
- Efficacy and Safety of Ginkgo Diterpene Lactone Meglumine in Acute Ischemic StrokeJAMA Network Open, 2023
- Estimated Burden of Stroke in China in 2020JAMA Network Open, 2023
- Antiplatelet effect of ginkgo diterpene lactone meglumine injection in acute ischemic stroke: A randomized, double‐blind, placebo‐controlled clinical trialPhytotherapy Research, 2023
- Clinimetrics: Modified Rankin Scale (mRS)Journal of Physiotherapy, 2022
- Ginkgolide B targets and inhibits creatine kinase B to regulate the CCT/TRiC-SK1 axis and exerts pro-angiogenic activity in middle cerebral artery occlusion micePharmacological Research, 2022
- Ginkgo diterpene lactones inhibit cerebral ischemia/reperfusion induced inflammatory response in astrocytes via TLR4/NF-κB pathway in ratsJournal of Ethnopharmacology, 2020
- Why Most Acute Stroke Studies Are Positive in Animals but Not in Patients: A Systematic Comparison of Preclinical, Early Phase, and Phase 3 Clinical Trials of Neuroprotective AgentsAnnals of Neurology, 2019
- Exploring the neuroprotective effects of ginkgolides injection in a rodent model of cerebral ischemia–reperfusion injury by GC–MS based metabolomic profilingJournal of Pharmaceutical and Biomedical Analysis, 2017
- Neuroprotection for ischaemic stroke: Current status and challengesPharmacology & Therapeutics, 2015
- GRADE guidelines: 3. Rating the quality of evidenceJournal of Clinical Epidemiology, 2011